MarketPeel
Insider Trading Intelligence
JF

Jeff Frelick

BBLG
CHIEF EXECUTIVE OFFICER · BONE BIOLOGICS CORP · CIK 0001645093
FILING MIX · LIFETIME100%/0%
BUYS
7
SELLS
0
TOTAL VALUE
$11.6K
COMPANIES
1
ACTIVE SINCE
Jan 2022
HOLDINGS NOW
16,668
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jeff Frelick, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+6.86%-0.97%+7.84%+7.84%
14d2+100.00%+6.26%-1.64%+7.89%+7.89%
30d2+50.00%-5.76%-3.55%-2.21%-2.21%
60d2+0.00%-22.95%-4.40%-18.55%-18.55%
90d2+0.00%-36.84%+2.34%-39.19%-39.19%
180d2+0.00%-55.77%+14.20%-69.97%-69.97%
1y2+0.00%-76.78%+25.50%-102.28%-102.28%
2y2+0.00%-93.58%+47.74%-141.32%-141.32%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BBLG · 16,668 shares · as of Jan 8, 2026
035,03570,070105,105140,14020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 7 buys / 0 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
16,66816,668Jan 8, 2026Jan 20, 2026View →
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
54,11054,110Jan 15, 2025Jan 17, 2025View →
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
25,00025,000Jan 17, 2024Jan 19, 2024View →
BBLG
BONE BIOLOGICS CORP
PURCHASE
Chief Executive Officer
9,500$0.69$6.5K17,204Sep 11, 2023Sep 12, 2023View →
BBLG
BONE BIOLOGICS CORP
PURCHASE
Chief Executive Officer
7,600$0.66$5.0K7,704Aug 31, 2023Sep 5, 2023View →
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
37,750140,140Jan 25, 2023Mar 7, 2023View →
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
50,000102,389Jan 1, 2022Feb 28, 2022View →
Other insiders · BBLG
Loading peer insiders…
About this filer
CIK 0001645093
ROLE
Chief Executive Officer
PRIMARY
BBLG
COMPANIES
1
ACTIVE SINCE
Jan 2022
MARKETPEEL · /INSIDER/0001645093DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback